Clinical Trials on 雌激素受体阴性 in China
总计457个结果
-
Peking University First HospitalPeking University International Hospital; Beijing Geriatric Hospital; Beijing Changping Integrative...招聘中
-
First Affiliated Hospital of Harbin Medical University未知
-
The First Affiliated Hospital with Nanjing Medical...招聘中
-
Peking University First Hospital招聘中
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
The Third Xiangya Hospital of Central South UniversityThe Second People's Hospital of Huaihua; Yueyang Hospital of Traditional Chinese Medicine完全的
-
Guangdong Academy of Medical SciencesGuangzhou First People's Hospital; Guangzhou General Hospital of Guangzhou Military Command; Chinese...未知
-
Second Affiliated Hospital of Xi'an Jiaotong University招聘中
-
TenNor Therapeutics (Suzhou) Limited完全的
-
Lei Li招聘中复发性宫颈癌 | 放疗 | 免疫疗法 | 生存结果 | 免疫检查点抑制剂 | 客观反应率 | 转移性宫颈癌 | 替雷利珠单抗 | 持续性宫颈癌 | 抗程序性细胞死亡受体 1中国
-
Shandong UniversityZibo Central Hospital; Peking University Care Luzhong Hospital; Yuncheng Traditional Chinese Medicine... 和其他合作者尚未招聘
-
Shandong UniversityThe First Affiliated Hospital of Zhengzhou University; Zibo Central Hospital; Peking University... 和其他合作者尚未招聘
-
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd完全的
-
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd完全的
-
Lei Li招聘中宫颈癌 | 免疫疗法 | 生存结果 | 不良事件 | 局部晚期宫颈癌 | 放化疗 | 免疫检查点抑制剂 | 抗程序性细胞死亡受体 1 | Early Stage Cervical Cancer中国
-
Eisai Co., Ltd.完全的
-
Jiangsu HengRui Medicine Co., Ltd.Peking University Cancer Hospital & Institute完全的
-
Guangdong Provincial People's HospitalShanghai Junshi Bioscience Co., Ltd.招聘中非小细胞肺癌 | BRAF V600突变 | MET扩增 | MET 外显子 14 跳跃突变 | RET驱动突变 | Erb-B2 受体酪氨酸激酶外显子 20 突变中国
-
Jiangsu HengRui Medicine Co., Ltd.完全的
-
Zenith EpigeneticsPfizer; Newsoara Biopharma Co., Ltd.终止
-
Zhejiang Cancer Hospital招聘中晚期 HR 阳性和 HER2 阴性乳腺癌; CDK4/6抑制剂治疗失败中国
-
First People's Hospital of Hangzhou招聘中
-
Jiangsu Province Centers for Disease Control and...Chengdu Olymvax Biopharmaceuticals Inc.; PLA Army Medical University完全的
-
Jiangsu Province Centers for Disease Control and...Third Military Medical University; Chengdu Olymvax Biopharmaceuticals Inc.完全的
-
International Vaccine InstituteWellcome Trust; Centers for Disease Control and Prevention; University of Western Ontario, Canada 和其他合作者完全的
-
Second Affiliated Hospital of Xi'an Jiaotong University招聘中